SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

NCT00005822 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: doxorubicin hydrochloride
DRUG: semaxanib
PROCEDURE: conventional surgery
RADIATION: radiation therapy
DRUG: tamoxifen

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]